본문으로 건너뛰기
← 뒤로

ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology.

1/5 보강
European radiology 📖 저널 OA 34.3% 2022: 1/4 OA 2023: 0/7 OA 2024: 2/11 OA 2025: 18/71 OA 2026: 70/165 OA 2022~2026 2026 OA
Retraction 확인
출처

Agrotis G, Jäderling F, Lakhani A, Moreira ASL, Kekelidze M, Rembak-Szynkiewicz J

📝 환자 설명용 한 줄

MRI-based T-staging in prostate cancer enables more precise and individualised treatment decisions compared with traditional clinical T-staging, yet inconsistent image acquisition, interpretation, and

이 논문을 인용하기

↓ .bib ↓ .ris
APA Agrotis G, Jäderling F, et al. (2026). ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology.. European radiology. https://doi.org/10.1007/s00330-026-12397-8
MLA Agrotis G, et al.. "ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology.." European radiology, 2026.
PMID 41720935 ↗

Abstract

MRI-based T-staging in prostate cancer enables more precise and individualised treatment decisions compared with traditional clinical T-staging, yet inconsistent image acquisition, interpretation, and terminology limit reproducibility and clinical integration. This report recommends standardising MRI-based T-staging to strengthen its prognostic and therapeutic relevance. The prefix "mr" for MRI-based T-staging should be used, together with "extraprostatic extension" as the official radiologic term, replacing "extracapsular extension", to ensure consistency with pathology and the UICC TNM system. Within mrT3a disease, radiologists should differentiate "focal" from "established" extraprostatic extension, as established disease carries a higher recurrence risk and often requires more extensive surgical or radiotherapeutic management. Quality assurance programs, standardised acquisition protocols, and targeted education for radiologists and technologists are essential for improving interinstitutional consistency. Clinicians should incorporate proposed terminology and focal/established subclassification into structured reports and multidisciplinary discussions to refine risk stratification and guide nerve-sparing surgery or adjuvant therapy decisions. These coordinated measures will enhance the reproducibility and prognostic value of MRI-based T-staging, reduce overtreatment, and improve patient outcomes in contemporary prostate cancer management. KEY POINTS: The prefix "mr" should be added to T-staging for reporting and multidisciplinary team guidance, distinguishing it from clinical and pathological T-staging; extraprostatic extension should be explicitly defined as mrT3a. Staging assessment should be refined by subclassifying focal versus established extraprostatic extension to better guide risk stratification and treatment decisions. More reproducible and objective criteria of MRI-derived parameters should be adopted to reduce interpretation variability and to improve reader reproducibility.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (4)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기